Angion Biomedica Corp is a biotechnology business based in the US. Angion Biomedica Corp shares (ANGN) are listed on the NASDAQ and all prices are listed in US Dollars. Angion Biomedica Corp employs 3 staff and has a trailing 12-month revenue of around $653,000.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $1.00 |
|---|---|
| 52-week range | $0.00 - $0.00 |
| 50-day moving average | $7.17 |
| 200-day moving average | $8.11 |
| Wall St. target price | $1.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-10.11 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1 from 2023-06-01
| 1 week (2024-07-13) | N/A |
|---|---|
| 1 month (2024-06-20) | N/A |
| 3 months (2024-04-20) | N/A |
| 6 months (2024-01-20) | N/A |
| 1 year (2023-07-20) | N/A |
|---|---|
| 2 years (2022-07-22) | -3.85% |
| 3 years (2021-07-23) | 10.75 |
| 5 years (2019-07-20) | N/A |
| Revenue TTM | $653,000 |
|---|---|
| Gross profit TTM | $-15,799,000 |
| Return on assets TTM | -20.89% |
| Return on equity TTM | -54.47% |
| Profit margin | 0% |
| Book value | $1.32 |
| Market Capitalization | $30.1 million |
TTM: trailing 12 months
We're not expecting Angion Biomedica Corp to pay a dividend over the next 12 months.
Angion Biomedica Corp's shares were split on a 1:10 basis on 1 June 2023. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Angion Biomedica Corp shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Angion Biomedica Corp shares which in turn could have impacted Angion Biomedica Corp's share price.
Over the last 12 months, Angion Biomedica Corp's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Angion Biomedica Corp's is 0.5984. This would suggest that Angion Biomedica Corp's shares are less volatile than average (for this exchange).
To put Angion Biomedica Corp's beta into context you can compare it against those of similar companies.
Angion Biomedica Corp. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for chronic and progressive fibrotic diseases in the United States. The company develops ANG-3070, an oral tyrosine kinase receptor inhibitor for fibrotic diseases in kidney and lung. It also develops ROCK2 inhibitors for fibrotic diseases; CYP11B2, an inhibitor program for aldosterone-related diseases, including resistant hypertension, congestive heart failure, renal fibrosis, and hyperaldosteronism; and CYP26 for the degradation of retinoic acid. Angion Biomedica Corp. was incorporated in 1998 and is based in Uniondale, New York. .
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.